Opportunity
Simpler Grants.gov #HT942526NFRPEHDA
Neurofibromatosis Research Program Exploration-Hypothesis Development Award Opportunity
Buyer
Defense Health Agency Contracting Activity - DHACA
Posted
June 25, 2026
Respond By
September 22, 2026
Identifier
HT942526NFRPEHDA
NAICS
541715
This opportunity from the Defense Health Agency Contracting Activity (DHACA) seeks proposals for the Neurofibromatosis Research Program Exploration-Hypothesis Development Award. - Government Buyer: - Defense Health Agency Contracting Activity (DHACA), Department of Defense - Congressionally Directed Medical Research Programs (CDMRP) - OEMs and Vendors: - No specific OEMs or vendors are mentioned; this is a research grant opportunity - Products/Services Requested: - Innovative, high-risk, high-gain research projects in neurofibromatosis (NF) - Up to 8 awards, each with a maximum total cost cap of $160,000 - Maximum period of performance: 2 years per award - Unique/Notable Requirements: - Projects must introduce novel paradigms or challenge existing ones - Preliminary data is encouraged but not required - Broad eligibility: domestic and foreign, for-profit and nonprofit organizations, public or private entities - Focus on hypothesis-driven research with strong scientific rationale and study design - Estimated total funding: $1,280,000 for all awards
Description
The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. The award aims to fund studies that lay the groundwork for future scientific investigation avenues. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. Innovation is a key feature, encouraging novel paradigms or perspectives, and preliminary data is encouraged but not required.